MedTrace Logo

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders

NCT05455996 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-05

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of MDMA-Assisted Therapy on Frontline Health Care Workers and First Responders suffering from symptoms of Post-Traumatic Stress.

Conditions

  • Post-Traumatic Stress Disorder
  • Adjustment Disorders

Interventions

DRUG

MDMA

MDMA-assisted therapy

Sponsors & Collaborators

  • Nautilus Psychiatric Services, PLLC

    collaborator OTHER

  • Nautilus Sanctuary

    lead OTHER

Principal Investigators

  • Willa Hall, Ph.D. · Nautilus Sanctuary

  • Casey Paleos, M.D. · InnerMost PBC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2028-01-31
Completion
2028-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05455996 on ClinicalTrials.gov